Robert A. Beardsley
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert A. Beardsley
Earlier roles on record: COO at Galera Therapeutics, Inc. (GRTXD) until June 4, 2024. Galera Therapeutics, Inc. reported in an 8-K filed June 7, 2024 that Robert A. Beardsley was terminated as Chief Operating Officer, effective June 4, 2024. The proxy statement of Galera Therapeutics, Inc. reports total compensation of $1,449,913 for Robert A. Beardsley in fiscal 2020, including a base salary of $422,000. Disclosed compensation is on record for 3 fiscal years.
“On June 4, 2024, Galera Therapeutics, Inc. (the "Company") notified Robert A. Beardsley, Ph.D., the Company's Chief Operating Officer, that his position is being eliminated in order to save costs as the Company continues to undertake a comprehensive review of strategic alternatives for both the Company and its portfolio of dismutase mimetics.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-06-04
-
Start not stated–2024-06-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Galera Therapeutics, Inc. (GRTXD) | Ph.D., Chief Operating Officer | $422,000 | $1,449,913 |
| 2019 | Galera Therapeutics, Inc. (GRTXD) | Ph.D., Chief Operating Officer | $358,476 | $1,668,213 |
| 2018 | Galera Therapeutics, Inc. (GRTXD) | Ph.D., Chief Operating Officer | $325,696 | $423,405 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.